{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T16:49:09Z","timestamp":1743007749908,"version":"3.40.3"},"publisher-location":"Cham","reference-count":115,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783031598142"},{"type":"electronic","value":"9783031598159"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-3-031-59815-9_5","type":"book-chapter","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T22:01:55Z","timestamp":1723154515000},"page":"43-58","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Laboratory Features and Pathology of Cytokine Storm Syndromes"],"prefix":"10.1007","author":[{"given":"Flavia\u00a0G.","family":"Rosado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Purva","family":"Gopal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,9]]},"reference":[{"key":"5_CR1","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1055\/s-0029-1237386","volume":"221","author":"G Janka","year":"2009","unstructured":"Janka G. Hemophagocytic lymphohistiocytosis: when the immune system runs amok. Klin Padiatr. 2009;221:278\u201385.","journal-title":"Klin Padiatr"},{"key":"5_CR2","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/art.20198","volume":"50","author":"AA Grom","year":"2004","unstructured":"Grom AA. Natural killer cell dysfunction: a common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis? Arthritis Rheum. 2004;50:689\u201398.","journal-title":"Arthritis Rheum"},{"key":"5_CR3","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1309\/AJCP4ZDKJ4ICOUAT","volume":"139","author":"FGN Rosado","year":"2013","unstructured":"Rosado FGN, Kim AS. Hemophagocytic lymphohistiocytosis: an update on diagnosis and pathogenesis. Am J Clin Pathol. 2013;139:713\u201327.","journal-title":"Am J Clin Pathol"},{"key":"5_CR4","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nri3839","volume":"15","author":"I Voskoboinik","year":"2015","unstructured":"Voskoboinik I, Whisstock JC, Trapani JA. Perforin and granzymes: function, dysfunction and human pathology. Nat Rev Immunol. 2015;15:388\u2013400.","journal-title":"Nat Rev Immunol"},{"key":"5_CR5","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1086\/318796","volume":"68","author":"EK Goransdotter","year":"2001","unstructured":"Goransdotter EK, Fadeel B, Nilsson-Ardnor S, et al. Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis. Am J Hum Genet. 2001;68:590\u20137.","journal-title":"Am J Hum Genet"},{"key":"5_CR6","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1126\/science.286.5446.1957","volume":"286","author":"SE Stepp","year":"1999","unstructured":"Stepp SE, Dufourcq-Lagelouse R, Le Deist F, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 1999;286:1957\u20139.","journal-title":"Science"},{"key":"5_CR7","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.0105-2896.2005.00224.x","volume":"203","author":"G Menasche","year":"2005","unstructured":"Menasche G, Feldmann J, Fischer A, et al. Primary hemophagocytic syndromes point to a direct link between lymphocyte cytotoxicity and homeostasis. Immunol Rev. 2005;203:165\u201379.","journal-title":"Immunol Rev"},{"key":"5_CR8","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/335448a0","volume":"335","author":"MG Lichtenheld","year":"1988","unstructured":"Lichtenheld MG, Olsen KJ, Lu P, et al. Structure and function of human perforin. Nature. 1988;335:448\u201351.","journal-title":"Nature"},{"issue":"5","key":"5_CR9","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1097\/CCM.0000000000005361","volume":"50","author":"MR Hines","year":"2022","unstructured":"Hines MR, von Bahr GT, Beutel G, Beutel K, Hays JA, Horne A, et al. Consensus-based guidelines for the recognition, diagnosis, and management of hemophagocytic lymphohistiocytosis in critically Ill children and adults. Crit Care Med. 2022;50(5):860\u201372.","journal-title":"Crit Care Med"},{"key":"5_CR10","unstructured":"Zhang K, Filipovich AH, Johnson J, et al. Hemophagocytic lymphohistiocytosis, familial. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews\u00ae. Seattle: University of Washington, Seattle. p. 1993\u20132017."},{"key":"5_CR11","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1086\/302187","volume":"64","author":"M Ohadi","year":"1999","unstructured":"Ohadi M, Lalloz MR, Sham P, et al. Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3-22 by homozygosity mapping. Am J Hum Genet. 1999;64:165\u201371.","journal-title":"Am J Hum Genet"},{"key":"5_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jim.2010.11.006","volume":"364","author":"TS Johnson","year":"2011","unstructured":"Johnson TS, Villanueva J, Filipovich AH, et al. Contemporary diagnostic methods for hemophagocytic lymphohistiocytic disorders. J Immunol Methods. 2011;364:1\u201313.","journal-title":"J Immunol Methods"},{"key":"5_CR13","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1365-2249.2010.04302.x","volume":"163","author":"C Gholam","year":"2011","unstructured":"Gholam C, Grigoriadou S, Gilmour KC, et al. Familial haemophagocytic lymphohistiocytosis: advances in the genetic basis, diagnosis and management. Clin Exp Immunol. 2011;163:271\u201383.","journal-title":"Clin Exp Immunol"},{"key":"5_CR14","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0092-8674(03)00855-9","volume":"115","author":"J Feldmann","year":"2003","unstructured":"Feldmann J, Callebaut I, Raposo G, et al. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell. 2003;115:461\u201373.","journal-title":"Cell"},{"key":"5_CR15","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/hmg\/ddi076","volume":"14","author":"U Zur Stadt","year":"2005","unstructured":"Zur Stadt U, Schmidt S, Kasper B, et al. Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Hum Mol Genet. 2005;14:827\u201334.","journal-title":"Hum Mol Genet"},{"key":"5_CR16","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.ajhg.2009.09.005","volume":"85","author":"U Zur Stadt","year":"2009","unstructured":"Zur Stadt U, Rohr J, Seifert W, et al. Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11. Am J Hum Genet. 2009;85:482\u201392.","journal-title":"Am J Hum Genet"},{"key":"5_CR17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1080\/07853890500465189","volume":"38","author":"JW Verbsky","year":"2006","unstructured":"Verbsky JW, Grossman WJ. Hemophagocytic lymphohistiocytosis: diagnosis, pathophysiology, treatment, and future perspectives. Ann Med. 2006;38:20\u201331.","journal-title":"Ann Med"},{"issue":"14","key":"5_CR18","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1182\/blood-2013-11-538686","volume":"123","author":"FY Li","year":"2014","unstructured":"Li FY, Chaigne-Delalande B, Su H, Uzel G, Matthews H, Lenardo MJ. XMEN disease: a new primary immunodeficiency affecting Mg2+ regulation of immunity against Epstein-Barr virus. Blood. 2014;123(14):2148\u201352.","journal-title":"Blood"},{"key":"5_CR19","first-page":"1","volume":"0","author":"FG Rosado","year":"2016","unstructured":"Rosado FG, Rinker EB, Plummer WD, Dupont WD, Spradlin NM, Reichard KK, Kim AS. The diagnosis of adult-onset haemophagocytic lymphohistiocytosis: lessons learned from a review of 29 cases of bone marrow haemophagocytosis in two large academic institutions. J Clin Pathol. 2016;0:1\u20135.","journal-title":"J Clin Pathol"},{"key":"5_CR20","first-page":"271","volume":"31","author":"J Puente","year":"1993","unstructured":"Puente J, Carvajal T, Parra S, et al. In vitro studies of natural killer cell activity in septic shock patients: response to a challenge with alpha-interferon and interleukin-2. Int J Clin Pharmacol Ther Toxicol. 1993;31:271\u20135.","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"5_CR21","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1086\/522429","volume":"196","author":"L von Muller","year":"2007","unstructured":"von Muller L, Klemm A, Durmus N, et al. Cellular immunity and active human cytomegalovirus infection in patients with septic shock. J Infect Dis. 2007;196:1288\u201395.","journal-title":"J Infect Dis"},{"key":"5_CR22","first-page":"5738","volume":"7","author":"MC Smith","year":"2014","unstructured":"Smith MC, Cohen DN, Greig B, et al. The ambiguous boundary between EBV-related hemophagocytic lymphohistiocytosis and systemic EBV-driven T cell lymphoproliferative disorder. Int J Clin Exp Pathol. 2014;7:5738\u201349.","journal-title":"Int J Clin Exp Pathol"},{"key":"5_CR23","first-page":"29","volume":"18","author":"JI Henter","year":"1991","unstructured":"Henter JI, Elinder G, Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol. 1991;18:29\u201333.","journal-title":"Semin Oncol"},{"key":"5_CR24","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s10067-020-05569-4","volume":"40","author":"S Retamozo","year":"2021","unstructured":"Retamozo S, Brito-Zer\u00f3n P, Sis\u00f3-Almirall A, et al. Haemophagocytic syndrome and COVID-19. Clin Rheumatol. 2021;40:1233\u201344.","journal-title":"Clin Rheumatol"},{"key":"5_CR25","first-page":"1219","volume":"144","author":"IJ Su","year":"1994","unstructured":"Su IJ, Chen RL, Lin DT, et al. Epstein-Barr virus (EBV) infects T lymphocytes in childhood EBV-associated hemophagocytic syndrome in Taiwan. Am J Pathol. 1994;144:1219\u201325.","journal-title":"Am J Pathol"},{"key":"5_CR26","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1182\/blood.V98.6.1882","volume":"98","author":"Y Kasahara","year":"2001","unstructured":"Kasahara Y, Yachie A, Takei K, et al. Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Blood. 2001;98:1882\u20138.","journal-title":"Blood"},{"key":"5_CR27","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1172\/JCI119728","volume":"100","author":"JD Lay","year":"1997","unstructured":"Lay JD, Tsao CJ, Chen JY, et al. Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus\u2013infected T cells in the pathogenesis of hemophagocytic syndrome. J Clin Invest. 1997;100:1969\u201379.","journal-title":"J Clin Invest"},{"key":"5_CR28","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1182\/blood-2005-04-1406","volume":"106","author":"HC Chuang","year":"2005","unstructured":"Chuang HC, Lay JD, Hsieh WC, et al. Epstein-Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome. Blood. 2005;106:3090\u20136.","journal-title":"Blood"},{"key":"5_CR29","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1172\/JCI116721","volume":"92","author":"H Kawaguchi","year":"1993","unstructured":"Kawaguchi H, Miyashita T, Herbst H, et al. Epstein-Barr virus\u2013infected T lymphocytes in Epstein-Barr virus\u2013associated hemophagocytic syndrome. J Clin Invest. 1993;92:1444\u201350.","journal-title":"J Clin Invest"},{"key":"5_CR30","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S1040-8428(02)00119-1","volume":"44","author":"Y Kasahara","year":"2002","unstructured":"Kasahara Y, Yachie A. Cell type specific infection of Epstein-Barr virus (EBV) in EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Crit Rev Oncol Hematol. 2002;44:283\u201394.","journal-title":"Crit Rev Oncol Hematol"},{"key":"5_CR31","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1111\/j.1349-7006.2007.00549.x","volume":"98","author":"HC Chuang","year":"2007","unstructured":"Chuang HC, Lay JD, Hsieh WC, et al. Pathogenesis and mechanism of disease progression from hemophagocytic lymphohistiocytosis to Epstein-Barr virus\u2013associated T-cell lymphoma: nuclear factor-kappa B pathway as a potential therapeutic target. Cancer Sci. 2007;98:1281\u20137.","journal-title":"Cancer Sci"},{"issue":"12","key":"5_CR32","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/acr2.11331","volume":"3","author":"DD Reiff","year":"2021","unstructured":"Reiff DD, Cron RQ. Performance of cytokine storm syndrome scoring systems in pediatric COVID-19 and multisystem inflammatory syndrome in children. ACR Open Rheumatol. 2021;3(12):820\u20136.","journal-title":"ACR Open Rheumatol"},{"key":"5_CR33","doi-asserted-by":"publisher","first-page":"59977","DOI":"10.18632\/oncotarget.19230","volume":"8","author":"H Wang","year":"2017","unstructured":"Wang H, Xiong L, Tang W, Zhou Y, Li F. A systematic review of malignancy-associated hemophagocytic lymphohistiocytosis that needs more attentions. Oncotarget. 2017;8:59977\u201385.","journal-title":"Oncotarget"},{"issue":"1","key":"5_CR34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40425-018-0365-3","volume":"6","author":"M Sadaat","year":"2018","unstructured":"Sadaat M, Jang S. Hemophagocytic lymphohistiocytosis with immunotherapy: brief review and case report. J Immunother Cancer. 2018;6(1):49.","journal-title":"J Immunother Cancer"},{"issue":"4","key":"5_CR35","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/bjh.17662","volume":"194","author":"MR Hines","year":"2021","unstructured":"Hines MR, Keenan C, Maron Alfaro G, Cheng C, Zhou Y, Sharma A, et al. Hemophagocytic lymphohistiocytosis-like toxicity (carHLH) after CD19-specific CAR T-cell therapy. Br J Haematol. 2021;194(4):701\u20137.","journal-title":"Br J Haematol"},{"key":"5_CR36","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000312628","volume":"153","author":"S Deane","year":"2010","unstructured":"Deane S, Selmi C, Teuber SS, et al. Macrophage activation syndrome in autoimmune disease. Int Arch Allergy Immunol. 2010;153:109\u201320.","journal-title":"Int Arch Allergy Immunol"},{"key":"5_CR37","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1146\/annurev-med-041610-134208","volume":"63","author":"GE Janka","year":"2012","unstructured":"Janka GE. Familial and acquired hemophagocytic lymphohistiocytosis. Annu Rev Med. 2012;63:233\u201346.","journal-title":"Annu Rev Med"},{"key":"5_CR38","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.critrevonc.2004.01.002","volume":"50","author":"JI Henter","year":"2004","unstructured":"Henter JI, Tondini C, Pritchard J. Histiocyte disorders. Crit Rev Oncol Hematol. 2004;50:157\u201374.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"9","key":"5_CR39","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s11926-014-0439-2","volume":"16","author":"M Zhang","year":"2014","unstructured":"Zhang M, Behrens EM, Atkinson TP, Shakoory B, Grom AA, Cron RQ. Genetic defects in cytolysis in macrophage activation syndrome. Curr Rheumatol Rep. 2014;16(9):439.","journal-title":"Curr Rheumatol Rep"},{"issue":"12","key":"5_CR40","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.1002\/art.38793","volume":"66","author":"KM Kaufman","year":"2014","unstructured":"Kaufman KM, Linghu B, Szustakowski JD, et al. Whole-exome sequencing reveals overlap between macrophage activation syndrome in systemic juvenile idiopathic arthritis and familial hemophagocytic lymphohistiocytosis. Arthritis Rheum. 2014;66(12):3486\u201395.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"5_CR41","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/rheumatology\/kep418","volume":"49","author":"SJ Vastert","year":"2010","unstructured":"Vastert SJ, van Wijk R, D'Urbano LE, et al. Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis. Rheumatology (Oxford). 2010;49(3):441\u20139.","journal-title":"Rheumatology (Oxford)"},{"key":"5_CR42","first-page":"82","volume-title":"ASH education book","author":"G Janka","year":"2005","unstructured":"Janka G, Zur Stadt U. Familial and acquired hemophagocytic lymphohistiocytosis. In: ASH education book, vol. 1; 2005. p. 82\u20138."},{"issue":"10","key":"5_CR43","doi-asserted-by":"publisher","first-page":"775","DOI":"10.2169\/internalmedicine.48.1677","volume":"48","author":"M Okamoto","year":"2009","unstructured":"Okamoto M, Yamaguchi H, Isobe Y, et al. Analysis of triglyceride value in the diagnosis and treatment response of secondary hemophagocytic syndrome. Intern Med. 2009;48(10):775.","journal-title":"Intern Med"},{"key":"5_CR44","doi-asserted-by":"crossref","unstructured":"Lorenz F, Klimkowska M, Paw\u0142owicz E, et al. Clinical characteristics, therapy response, and outcome of 51 adult patients with hematological malignancy-associated hemophagocytic lymphohistiocytosis: a single institution experience. Leuk Lymphoma. 2018;(Jan 3):1\u201311.","DOI":"10.1080\/10428194.2017.1403018"},{"issue":"Suppl 1","key":"5_CR45","doi-asserted-by":"publisher","first-page":"O84","DOI":"10.1186\/1546-0096-13-S1-O84","volume":"13","author":"C Bracaglia","year":"2015","unstructured":"Bracaglia C, Marafon DP, Caiello I, et al. High levels of interferon-gamma (IFN\u03b3) in macrophage activation syndrome (MAS) and CXCL9 levels as a biomarker for IFN\u03b3 production in MAS. Pediatr Rheumatol Online J. 2015;13(Suppl 1):O84.","journal-title":"Pediatr Rheumatol Online J"},{"key":"5_CR46","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jaut.2007.11.003","volume":"30","author":"S Recalcati","year":"2008","unstructured":"Recalcati S, Invernizzi P, Arosio P, et al. New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity. J Autoimmun. 2008;30:84\u20139.","journal-title":"J Autoimmun"},{"key":"5_CR47","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/BOR.0b013e32825a6a79","volume":"19","author":"A Kelly","year":"2007","unstructured":"Kelly A, Ramanan AV. Recognition and management of macrophage activation syndrome in juvenile arthritis. Curr Opin Rheumatol. 2007;19:477\u201381.","journal-title":"Curr Opin Rheumatol"},{"key":"5_CR48","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/rheumatology\/key006","volume":"58","author":"SJ Carter","year":"2019","unstructured":"Carter SJ, Tattersall RS, Ramanan AV. Macrophage activation syndrome in adults: recent advances in pathophysiology, diagnosis, and treatment. Rheumatology. 2019;58:5\u201317.","journal-title":"Rheumatology"},{"key":"5_CR49","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s40272-019-00367-1","volume":"22","author":"LA Henderson","year":"2020","unstructured":"Henderson LA, Cron RQ. Macrophage activation syndrome and secondary hemophagocytic lymphohistiocytosis in childhood inflammatory disorders: diagnosis and management. Pediatr Drugs. 2020;22:29\u201344.","journal-title":"Pediatr Drugs"},{"issue":"10","key":"5_CR50","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1136\/annrheumdis-2019-215211","volume":"78","author":"F Minoia","year":"2019","unstructured":"Minoia F, Bovis F, Dav\u00ec S, Horne A, Fischbach M, Frosch M, et al. Pediatric Rheumatology International Trials Organization, the Childhood Arthritis & Rheumatology Research Alliance, the Pediatric Rheumatology Collaborative Study Group and the Histiocyte Society. Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Ann Rheum Dis. 2019;78(10):1357\u201362.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"5_CR51","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/acr2.11048","volume":"1","author":"EMA Eloseily","year":"2019","unstructured":"Eloseily EMA, Minoia F, Crayne CB, Beukelman T, Ravelli A, Cron RQ. Ferritin to erythrocyte sedimentation rate ratio: simple measure to identify macrophage activation syndrome in systemic juvenile idiopathic arthritis. ACR Open Rheumatol. 2019;1(6):345\u20139.","journal-title":"ACR Open Rheumatol"},{"issue":"3","key":"5_CR52","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/S0022-3476(97)70196-3","volume":"130","author":"JI Henter","year":"1997","unstructured":"Henter JI, Nennesmo I. Neuropathologic findings and neurologic symptoms in twenty-three children with hemophagocytic lymphohistiocytosis. J Pediatr. 1997;130(3):358.","journal-title":"J Pediatr"},{"issue":"1\u20132","key":"5_CR53","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jns.2015.07.017","volume":"357","author":"SM Gratton","year":"2015","unstructured":"Gratton SM, Powell TR, Theeler BJ, et al. Neurological involvement and characterization in acquired hemophagocytic lymphohistiocytosis in adulthood. J Neurol Sci. 2015;357(1\u20132):136\u201342.","journal-title":"J Neurol Sci"},{"issue":"11","key":"5_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27929","volume":"66","author":"MB Jordan","year":"2019","unstructured":"Jordan MB, Allen CE, Greenberg J, Henry M, Hermiston ML, Kumar A, et al. Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: recommendations from the North American Consortium for Histiocytosis (NACHO). Pediatr Blood Cancer. 2019;66(11):e27929.","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"5_CR55","doi-asserted-by":"publisher","first-page":"337","DOI":"10.55563\/clinexprheumatol\/xcdary","volume":"38","author":"P Sarzi-Puttini","year":"2020","unstructured":"Sarzi-Puttini P, Giorgi V, Sirotti S, Marotto D, Ardizzone S, Rizzardini G, et al. COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? Clin Exp Rheumatol. 2020;38(2):337\u201342.","journal-title":"Clin Exp Rheumatol"},{"issue":"10229","key":"5_CR56","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta P, McAuley D, Brown M, Sanchez E, Tattersall RS, Manson J. COVID-19: consider cytokine storm syndrome and immunosuppression. Lancet. 2020;395(10229):1033\u20134.","journal-title":"Lancet"},{"issue":"4","key":"5_CR57","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/gene.2012.3","volume":"13","author":"A Ravelli","year":"2012","unstructured":"Ravelli A, Grom AA, Behrens EM, Cron RQ. Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment. Genes Immun. 2012;13(4):289\u201398.","journal-title":"Genes Immun"},{"key":"5_CR58","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.anndiagpath.2011.03.009","volume":"16","author":"S Lai","year":"2012","unstructured":"Lai S, Merritt BY, Chen L, et al. Hemophagocytic lymphohistiocytosis associated with influenza A (H1N1) infection in a patient with chronic lymphocytic leukemia: an autopsy case report and review of the literature. Ann Diagn Pathol. 2012;16:477\u201384.","journal-title":"Ann Diagn Pathol"},{"key":"5_CR59","volume-title":"Bone marrow pathology","author":"K Foucar","year":"2010","unstructured":"Foucar K. Histiocytic disorders in bone marrow. In: Foucar K, Reichard K, Czuchlewski D, editors. Bone marrow pathology. 3rd ed. Chicago: American Society for Clinical Pathology; 2010.","edition":"3"},{"key":"5_CR60","volume-title":"Hematopathology: a volume in foundations in diagnostic pathology series","author":"ED Hsi","year":"2007","unstructured":"Hsi ED. Hematopathology: a volume in foundations in diagnostic pathology series. London: Churchill Livingstone; 2007."},{"key":"5_CR61","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/j.1529-8019.2010.01339.x","volume":"23","author":"IK Aronson","year":"2010","unstructured":"Aronson IK, Worobec SM. Cytophagic histiocytic panniculitis and hemophagocytic lymphohistiocytosis: an overview. Dermatol Ther. 2010;23:389\u2013402.","journal-title":"Dermatol Ther"},{"issue":"11","key":"5_CR62","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1002\/art.38802","volume":"66","author":"F Minoia","year":"2014","unstructured":"Minoia F, Dav\u00ec S, Horne A, et al. Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients. Arthritis Rheum. 2014;66(11):3160\u20139.","journal-title":"Arthritis Rheum"},{"key":"5_CR63","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1097\/PAS.0b013e3181dbbb17","volume":"34","author":"JH Chen","year":"2010","unstructured":"Chen JH, Fleming MD, Pinkus GS, et al. Pathology of the liver in familial hemophagocytic lymphohistiocytosis. Am J Surg Pathol. 2010;34:852\u201367.","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"5_CR64","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1046\/j.1365-2559.1998.00377.x","volume":"32","author":"A Ost","year":"1998","unstructured":"Ost A, Nilsson-Ardnor S, Henter JI. Autopsy findings in 27 children with haemophagocytic lymphohistiocytosis. Histopathology. 1998;32(4):310.","journal-title":"Histopathology"},{"key":"5_CR65","volume-title":"Hematopathology","author":"SA Rezk","year":"2011","unstructured":"Rezk SA, Sullivan J, Woda B. Non-neoplastic histiocytic proliferations of lymph nodes and bone marrow. In: Jaffe ES, Harris NL, Vardiman JW, Campo E, Arber DA, editors. Hematopathology. Philadelphia: Elsevier Saunders; 2011."},{"key":"5_CR66","volume-title":"Atlas of lymph node pathology","author":"Hemophagocytic Lymphohistiocytosis\/Hemophagocytic syndromes","year":"2013","unstructured":"Hemophagocytic Lymphohistiocytosis\/Hemophagocytic syndromes. In: Miranda RN, Khoury JD, Medeiros LJ, editors. Atlas of lymph node pathology. New York: Springer; 2013."},{"issue":"8","key":"5_CR67","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1001\/jamadermatol.2016.0978","volume":"152","author":"JW Millsop","year":"2016","unstructured":"Millsop JW, Ho B, Kiuru M, et al. Cutaneous hemophagocytosis: bean bags from the bone. JAMA Dermatol. 2016;152(8):950\u20132.","journal-title":"JAMA Dermatol"},{"key":"5_CR68","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S1568-9972(03)00091-0","volume":"3","author":"C Larroche","year":"2004","unstructured":"Larroche C, Mouthon L. Pathogenesis of hemophagocytic syndrome (HPS). Autoimmun Rev. 2004;3:69\u201375.","journal-title":"Autoimmun Rev"},{"key":"5_CR69","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1097\/00043426-200309000-00002","volume":"25","author":"EM Schneider","year":"2003","unstructured":"Schneider EM, Lorenz I, Walther P, et al. Natural killer deficiency: a minor or major factor in the manifestation of hemophagocytic lymphohistiocytosis? J Pediatr Hematol Oncol. 2003;25:680\u20133.","journal-title":"J Pediatr Hematol Oncol"},{"key":"5_CR70","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/jcp.1041650312","volume":"165","author":"C Selleri","year":"1995","unstructured":"Selleri C, Sato T, Anderson S, et al. Interferon-gamma and tumor necrosis factor\u2013alpha suppress both early and late stages of hematopoiesis and induce programmed cell death. J Cell Physiol. 1995;165:538\u201346.","journal-title":"J Cell Physiol"},{"key":"5_CR71","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00431-006-0258-1","volume":"166","author":"GE Janka","year":"2007","unstructured":"Janka GE. Familial and acquired hemophagocytic lymphohistiocytosis. Eur J Pediatr. 2007;166:95\u2013109.","journal-title":"Eur J Pediatr"},{"key":"5_CR72","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1136\/adc.2009.176610","volume":"96","author":"HR Freeman","year":"2011","unstructured":"Freeman HR, Ramanan AV. Review of haemophagocytic lymphohistiocytosis. Arch Dis Child. 2011;96:688\u201393.","journal-title":"Arch Dis Child"},{"issue":"2","key":"5_CR73","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ccc.2019.12.004","volume":"36","author":"S Valade","year":"2020","unstructured":"Valade S, Mariotte E, Azoulay E. Coagulation disorders in hemophagocytic lymphohistiocytosis\/macrophage activation syndrome. Crit Care Clin. 2020;36(2):415\u201326.","journal-title":"Crit Care Clin"},{"issue":"7","key":"5_CR74","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3899\/jrheum.121131","volume":"40","author":"M Gorelik","year":"2013","unstructured":"Gorelik M, Fall N, Altaye M, et al. Follistatin-like protein 1 and the ferritin\/erythrocyte sedimentation rate ratio are potential biomarkers for dysregulated gene expression and macrophage activation syndrome in systemic juvenile idiopathic arthritis. J Rheumatol. 2013;40(7):1191\u20139.","journal-title":"J Rheumatol"},{"key":"5_CR75","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S1471-4906(03)00181-9","volume":"24","author":"LE Otterbein","year":"2003","unstructured":"Otterbein LE, Soares MP, Yamashita K, et al. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol. 2003;24:449\u201355.","journal-title":"Trends Immunol"},{"issue":"9","key":"5_CR76","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1182\/blood-2009-11-253815","volume":"116","author":"LA Cohen","year":"2010","unstructured":"Cohen LA, Gutierrez L, Weiss A, et al. Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway. Blood. 2010;116(9):1574\u201384.","journal-title":"Blood"},{"key":"5_CR77","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1182\/blood-2015-01-551622","volume":"125","author":"AM Schram","year":"2015","unstructured":"Schram AM, Berliner N. How I treat hemophagocytic lymphohistiocytosis in the adult patient. Blood. 2015;125:2908\u201314.","journal-title":"Blood"},{"issue":"9","key":"5_CR78","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1002\/art.38690","volume":"66","author":"L Fardet","year":"2014","unstructured":"Fardet L, Galicier L, Lambotte O, et al. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheum. 2014;66(9):2613\u201320.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"5_CR79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094024","volume":"9","author":"G Hejblum","year":"2014","unstructured":"Hejblum G, Lambotte O, Galicier L, et al. A web-based delphi study for eliciting helpful criteria in the positive diagnosis of hemophagocytic syndrome in adult patients. PLoS One. 2014;9(4):e94024.","journal-title":"PLoS One"},{"issue":"3","key":"5_CR80","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/art.39332","volume":"68","author":"A Ravelli","year":"2016","unstructured":"Ravelli A, Minoia F, Dav\u00ec S, et al. 2016 Classification Criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a european league against rheumatism\/american college of rheumatology\/paediatric rheumatology international trials organisation collaborative initiative. Arthritis Rheum. 2016;68(3):566\u201376.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"5_CR81","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1002\/art.24883","volume":"60","author":"A Parodi","year":"2009","unstructured":"Parodi A, Dav\u00ec S, Pringe AB, et al. Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients. Arthritis Rheum. 2009;60(11):3388\u201399.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"5_CR82","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/ejh.13779","volume":"109","author":"L Bilston","year":"2022","unstructured":"Bilston L, Croden J, Taparia M, Karkhaneh M, Grossman J, Sun HL. Validation of the HScore and the HLH-2004 diagnostic criteria for the diagnosis of hemophagocytic lymphohistiocytosis in a multicenter cohort. Eur J Haematol. 2022;109(2):129\u201337.","journal-title":"Eur J Haematol"},{"issue":"7","key":"5_CR83","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1182\/blood.2021012764","volume":"139","author":"A Zoref-Lorenz","year":"2022","unstructured":"Zoref-Lorenz A, Murakami J, Hofstetter L, Iyer S, Alotaibi AS, Mohamed SF, et al. An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosis. Blood. 2022;139(7):1098\u2013110.","journal-title":"Blood"},{"issue":"7","key":"5_CR84","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1182\/blood.2021014675","volume":"139","author":"P La Ros\u00e9e","year":"2022","unstructured":"La Ros\u00e9e P. Detecting HLH in hematologic malignancies. Blood. 2022;139(7):961\u20133.","journal-title":"Blood"},{"issue":"2","key":"5_CR85","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/cei.13543","volume":"203","author":"JM Krei","year":"2021","unstructured":"Krei JM, M\u00f8ller HJ, Larsen JB. The role of interleukin-18 in the diagnosis and monitoring of hemophagocytic lymphohistiocytosis\/macrophage activation syndrome \u2013 a systematic review. Clin Exp Immunol. 2021;203(2):174\u201382.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"5_CR86","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2015-000161","volume":"2","author":"A Ravelli","year":"2016","unstructured":"Ravelli A, Minoia F, Dav\u00ec S, et al. Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. RMD Open. 2016;2(1):e000161.","journal-title":"RMD Open"},{"key":"5_CR87","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1002\/pbc.21423","volume":"50","author":"CE Allen","year":"2008","unstructured":"Allen CE, Yu X, Kozinetz CA, et al. Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2008;50:1227\u201335.","journal-title":"Pediatr Blood Cancer"},{"issue":"10","key":"5_CR88","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1182\/blood-2014-10-602607","volume":"125","author":"AM Schram","year":"2015","unstructured":"Schram AM, Campigotto F, Mullally A, et al. Marked hyperferritinemia does not predict for HLH in the adult population. Blood. 2015;125(10):1548.","journal-title":"Blood"},{"issue":"3","key":"5_CR89","doi-asserted-by":"publisher","first-page":"R616","DOI":"10.1186\/ar1721","volume":"7","author":"Y Kirino","year":"2005","unstructured":"Kirino Y, Takeno M, Iwasaki M, et al. Increased serum HO-1 in hemophagocytic syndrome and adult-onset Still's disease: use in the differential diagnosis of hyperferritinemia. Arthritis Res Ther. 2005;7(3):R616\u201324.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"5_CR90","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1309\/AJCPMD5TJEFOOVBW","volume":"141","author":"C Ho","year":"2014","unstructured":"Ho C, Yao X, Tian L, et al. Marrow assessment for hemophagocytic lymphohistiocytosis demonstrates poor correlation with disease probability. Am J Clin Pathol. 2014;141(1):62\u201371.","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"5_CR91","first-page":"21","volume":"42","author":"S Goel","year":"2012","unstructured":"Goel S, Polski JM, Imran H. Sensitivity and specificity of bone marrow hemophagocytosis in hemophagocytic lymphohistiocytosis. Ann Clin Lab Sci Winter. 2012;42(1):21\u20135.","journal-title":"Ann Clin Lab Sci Winter"},{"key":"5_CR92","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/art.22416","volume":"56","author":"J Bleesing","year":"2007","unstructured":"Bleesing J, Prada A, Siegel DM, et al. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Arthritis Rheum. 2007;56:965\u201371.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"5_CR93","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00277-013-1925-8","volume":"93","author":"T Tsuji","year":"2014","unstructured":"Tsuji T, Hirano T, Yamasaki H, Tsuji M, Tsuda H. A high sIL-2R\/ferritin ratio is a useful marker for the diagnosis of lymphoma-associated hemophagocytic syndrome. Ann Hematol. 2014;93(5):821\u20136.","journal-title":"Ann Hematol"},{"issue":"1","key":"5_CR94","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1600-0609.2004.00318.x","volume":"74","author":"DJ Schaer","year":"2005","unstructured":"Schaer DJ, Schleiffenbaum B, Kurrer M, et al. Soluble hemoglobin-haptoglobin scavenger receptor CD163 as a lineage-specific marker in the reactive hemophagocytic syndrome. Eur J Haematol. 2005;74(1):6\u201310.","journal-title":"Eur J Haematol"},{"key":"5_CR95","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1182\/blood-2004-09-3651","volume":"105","author":"Y Tabata","year":"2005","unstructured":"Tabata Y, Villanueva J, Lee SM, et al. Rapid detection of intracellular SH2D1A protein in cytotoxic lymphocytes from patients with X-linked lymphoproliferative disease and their family members. Blood. 2005;105:3066\u201371.","journal-title":"Blood"},{"key":"5_CR96","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1182\/blood.V99.1.61","volume":"99","author":"K Kogawa","year":"2002","unstructured":"Kogawa K, Lee SM, Villanueva J, et al. Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members. Blood. 2002;99:61\u20136.","journal-title":"Blood"},{"key":"5_CR97","first-page":"311","volume":"19","author":"LA Garcia-Astudillo","year":"2009","unstructured":"Garcia-Astudillo LA, Fontalba A, Mazorra F, et al. Severe course of community-acquired pneumonia in an adult patient who is heterozygous for Q481P in the perforin gene: are carriers of the mutation free of risk? J Investig Allergol Clin Immunol. 2009;19:311\u20136.","journal-title":"J Investig Allergol Clin Immunol"},{"key":"5_CR98","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/978-1-60761-362-6_23","volume":"612","author":"YT Bryceson","year":"2010","unstructured":"Bryceson YT, Fauriat C, Nunes JM, et al. Functional analysis of human NK cells by flow cytometry. Methods Mol Biol. 2010;612:335\u201352.","journal-title":"Methods Mol Biol"},{"key":"5_CR99","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1182\/blood-2006-04-015693","volume":"108","author":"S Marcenaro","year":"2006","unstructured":"Marcenaro S, Gallo F, Martini S, et al. Analysis of natural killer\u2013cell function in familial hemophagocytic lymphohistiocytosis (FHL): defective CD107a surface expression heralds Munc13-4 defect and discriminates between genetic subtypes of the disease. Blood. 2006;108:2316\u201323.","journal-title":"Blood"},{"issue":"8","key":"5_CR100","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1182\/blood-2012-07-441832","volume":"122","author":"A Cohnen","year":"2013","unstructured":"Cohnen A, Chiang S, Stojanovic A, Schmidt H, Claus M, Saftig P, et al. Surface CD107a\/LAMP-1 protects natural killer cells from degranulation-associated damage. Blood. 2013;122(8):1411\u20138.","journal-title":"Blood"},{"key":"5_CR101","doi-asserted-by":"crossref","unstructured":"Noori T, Rudd-Schmidt JA, Kane A, Frith K, Gray PE, Hu H, et al. A cell-based functional assay that accurately links genotype to phenotype in Familial HLH. Blood. 2023:blood.2022018398.","DOI":"10.1182\/blood.2022018398"},{"key":"5_CR102","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1182\/blood-2001-12-0260","volume":"100","author":"EM Schneider","year":"2002","unstructured":"Schneider EM, Lorenz I, Muller-Rosenberger M, et al. Hemophagocytic lymphohistiocytosis is associated with deficiencies of cellular cytolysis but normal expression of transcripts relevant to killer-cell\u2013induced apoptosis. Blood. 2002;100:2891\u20138.","journal-title":"Blood"},{"issue":"10","key":"5_CR103","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141074","volume":"10","author":"SS Somanchi","year":"2015","unstructured":"Somanchi SS, McCulley KJ, Somanchi A, et al. A novel method for assessment of natural killer cell cytotoxicity using image cytometry. PLoS One. 2015;10(10):e0141074.","journal-title":"PLoS One"},{"issue":"6","key":"5_CR104","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.4049\/jimmunol.1501284","volume":"196","author":"M Zhang","year":"2016","unstructured":"Zhang M, Bracaglia C, Prencipe G, et al. A heterozygous RAB27A mutation associated with delayed cytolytic granule polarization and hemophagocytic lymphohistiocytosis. J Immunol. 2016;196(6):2492\u2013503.","journal-title":"J Immunol"},{"key":"5_CR105","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1046\/j.1365-2141.2003.04726.x","volume":"124","author":"GE Janka","year":"2004","unstructured":"Janka GE, Schneider EM. Modern management of children with haemophagocytic lymphohistiocytosis. Br J Haematol. 2004;124:4\u201314.","journal-title":"Br J Haematol"},{"key":"5_CR106","doi-asserted-by":"publisher","first-page":"538","DOI":"10.3324\/haematol.2009.019562","volume":"95","author":"V Cetica","year":"2010","unstructured":"Cetica V, Pende D, Griffiths GM, et al. Molecular basis of familial hemophagocytic lymphohistiocytosis. Haematologica. 2010;95:538\u201341.","journal-title":"Haematologica"},{"issue":"7","key":"5_CR107","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1093\/infdis\/jiv550","volume":"213","author":"GS Schulert","year":"2016","unstructured":"Schulert GS, Zhang M, Fall N, et al. Whole-exome sequencing reveals mutations in genes linked to hemophagocytic lymphohistiocytosis and macrophage activation syndrome in fatal cases of H1N1 Influenza. J Infect Dis. 2016;213(7):1180\u20138.","journal-title":"J Infect Dis"},{"issue":"10","key":"5_CR108","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1182\/blood-2014-11-610816","volume":"125","author":"WA Spessott","year":"2015","unstructured":"Spessott WA, Sanmillan ML, McCormick ME, et al. Hemophagocytic lymphohistiocytosis caused by dominant-negative mutations in STXBP2 that inhibit SNARE-mediated membrane fusion. Blood. 2015;125(10):1566\u201377.","journal-title":"Blood"},{"issue":"6","key":"5_CR109","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/art.40438","volume":"70","author":"GS Schulert","year":"2018","unstructured":"Schulert GS, Zhang M, Husami A, Fall N, Brunner H, Zhang K, Cron RQ, Grom AA. Brief report: novel UNC13D intronic variant disrupting an NF-\u03baB enhancer in a patient with recurrent macrophage activation syndrome and systemic juvenile idiopathic arthritis. Arthritis Rheum. 2018;70(6):963\u201370.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"5_CR110","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1084\/jem.20131131","volume":"211","author":"F Cichocki","year":"2014","unstructured":"Cichocki F, Schlums H, Li H, et al. Transcriptional regulation of Munc13-4 expression in cytotoxic lymphocytes is disrupted by an intronic mutation associated with a primary immunodeficiency. J Exp Med. 2014;211(6):1079\u201391.","journal-title":"J Exp Med"},{"issue":"3","key":"5_CR111","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41435-020-0098-4","volume":"21","author":"GS Schulert","year":"2020","unstructured":"Schulert GS, Cron RQ. The genetics of macrophage activation syndrome. Genes Immun. 2020;21(3):169\u201381.","journal-title":"Genes Immun"},{"issue":"7","key":"5_CR112","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1177\/0885066613517076","volume":"30","author":"Z Tothova","year":"2015","unstructured":"Tothova Z, Berliner N. Hemophagocytic syndrome and critical illness: new insights into diagnosis and management. J Intensive Care Med. 2015;30(7):401\u201312.","journal-title":"J Intensive Care Med"},{"issue":"6","key":"5_CR113","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.jpeds.2011.11.046","volume":"160","author":"XJ Xu","year":"2012","unstructured":"Xu XJ, Tang YM, Song H, Yang SL, Xu WQ, Zhao N, et al. Diagnostic accuracy of a specific cytokine pattern in hemophagocytic lymphohistiocytosis in children. J Pediatr. 2012;160(6):984\u201390.","journal-title":"J Pediatr"},{"issue":"2","key":"5_CR114","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.clim.2015.06.005","volume":"160","author":"M Shimizu","year":"2015","unstructured":"Shimizu M, Nakagishi Y, Inoue N, et al. Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Clin Immunol. 2015;160(2):277\u201381.","journal-title":"Clin Immunol"},{"issue":"9","key":"5_CR115","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.3390\/biomedicines10092161","volume":"10","author":"WC Yang","year":"2022","unstructured":"Yang WC, Lin SF, Wu SC, Shu CW. Matrin3 (MATR3) expression is associated with hemophagocytosis. Biomedicines. 2022;10(9):2161.","journal-title":"Biomedicines"}],"container-title":["Advances in Experimental Medicine and Biology","Cytokine Storm Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-59815-9_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T22:02:49Z","timestamp":1723154569000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-59815-9_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9783031598142","9783031598159"],"references-count":115,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-59815-9_5","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"9 August 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}